BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 24, 1999
View Archived Issues
Fluvastatin lowers LDL, raises HDL cholesterol
Read More
Genzyme Transgenics: Q4 and year-end 1998 highlights
Read More
Nabi: Q4 and year-end 1998 highlights
Read More
Millennium delivers seventh antibacterial drug target to Wyeth-Ayerst
Read More
Procept and Pacific Pharmaceuticals merge, pipeline updated
Read More
Genetronics receives CE Mark approval for MedPulser solid tumor treatment
Read More
Texas Biotechnology resubmits Novastan NDA
Read More
American Home Products patents selective, orally active, nonpeptide V2 agonists
Read More
Recordati presents new series for lower urinary tract dysfunction
Read More
Anti-MRSA cephems developed at Bristol-Myers Squibb
Read More
Integrin receptor antagonists disclosed by SB
Read More
Toyama searches for effective and safe quinolones
Read More
Kyowa Hakko and Cor select development candidates for inhibiting PDGF receptor phosphorylation
Read More
Favorable safety and PK/PD profiles reported for CFC-222
Read More
ACS highlights: 3-D progresses in development of new class of thrombin inhibitors
Read More
Dual dopamine D1/D5 antagonist blocks the rewarding effects of cocaine in humans
Read More
High-affinity RARalpha receptor agonists reported by Eisai at ACS meeting
Read More
Allos presents phase Ib results of RSR-13 in patients with angina
Read More
DuPont presents 4-aminoquinazoline cyclin-dependent kinase inhibitors
Read More
Pharmacokinetics of AMP-579 are affected by body weight but not by renal function
Read More
Ariad receives broader patent coverage for its ARGENT and Dimerizer Drugs technologies
Read More
Antiarrhythmic efficacy of Na+/Ca2+ exchange inhibitor demonstrated in preclinical models
Read More
Patent issued to GenVec covering gene delivery systems targeting specific tissues
Read More
Conformationally restricted CRF1 antagonists developed at Merck & Co.
Read More
Preclinical activity of JTH-601, a novel alpha-adrenoceptor antagonist from Japan Tobacco
Read More
Highly potent and selective sst2 receptor agonist: discovery and synthesis discussed at ACS meeting
Read More
ACS highlights: novel guanylureas as NPY Y1 antagonists presented by Alanex
Read More
Merck reveals progress in obesity/diabetes program at ACS meeting
Read More
New series of benzimidazole ribosides for HCMV infection discovered at Glaxo Wellcome
Read More
Highlights from ACS: potent and selective alpha2-blocker presented by Pierre Fabre
Read More
ACS presentation for LY-377604, Lilly's beta3-agonist for metabolic syndrome
Read More